Evidence map›Paper›PMID 41438703›Full record

ArticleMaterials today. Bio2025

Enhanced magnetic thermal ablation combined with immunotherapy for hepatocellular carcinoma using engineering microspheres.

Zepeng Yu, Yaping He, Mengmeng Wang, Jiaofeng Shen, Di Wang, Andong Yu, Jun Gu, Zhihui Hong, Zhijun Pei, Xingwei Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zepeng YuDepartment of Interventional Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Yaping HeDepartment of Radiotherapy & Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Mengmeng WangDepartment of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Jiaofeng ShenDepartment of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Di WangDepartment of Interventional Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Andong YuDepartment of Interventional Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Jun GuCenter for Medical Ultrasound, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, 215001, Jiangsu Province, China.
Zhihui HongDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Zhijun PeiDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
Xingwei SunDepartment of Interventional Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) remains a formidable challenge in oncology, characterized by high metastatic potential and recurrence rates. Traditional microwave ablation technique faces limitations due to operator dependency and potential complications. To address these challenges, we developed micron-sized polyacrylamide-iron carbonyl magnetic hyperthermia microspheres (PAM@Fe(CO)

Indexed as

Hepatocellular carcinomaMagnetic thermal ablationMicrospheresPD-1 monoclonal antibodiesTranscatheter arterial embolization

Identifiers

PMID41438703
PMCPMC12719205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.